Market Context — 2026-08-31 EOD Update (v54)
Geopolitics has escalated sharply and now leads the tape. US forces struck Iranian positions on Larak Island after an alleged Iranian sea-mine plot against Hormuz; Iran retaliated against US bases in Jordan/UAE. Oil spiked 3%+ above $86 WTI, reversing the prior de-escalation narrative — Pezeshkian's negotiation overtures to India now look overtaken by events. This is a live, two-sided risk: six-month retrospective shows Brent spiked $72→~$120 at peak and remains ~20% above prewar levels, yet equities have absorbed it (Dow +19%, S&P +22%, Nasdaq +27% off March lows), with AI capex offsetting war drag per IMF. Treat oil spikes as tradeable volatility, not yet a regime change, but Hormuz remains the tail risk to watch daily.
Warsh hawkish pivot is compounding with oil-driven inflation risk. September hike odds now 60-66%, 2yr yield 4.32-4.34%, bear-flattening intact. Gold/Bitcoin took the hit as scripted. Rising oil adds a second inflation vector alongside sticky core PCE (3.3%) — Schmid/Goolsbee/Posen all still hawkish, Posen wants two hikes before year-end. Rate-cut hopes remain dead; this thesis keeps playing out cleanly.
Memory/chip complex: fundamentals vs. positioning divergence is now the defining market anomaly. NVDA delivered (Q3 guide $108B, retail euphoric — NVDA/MRVL/CRM top buzz), yet EWY -20%, DRAM ETF -30%, Kospi -27% from peaks despite Micron/SK Hynix/SanDisk posting triple-digit growth, $100B+ buybacks, and SK Hynix guiding memory shortage through 2030. Micron now trades at ~6x forward earnings (3rd-cheapest in S&P 500) with new take-or-pay contracts through 2030 reducing downside — a legitimate re-rating setup. Marvell's post-earnings -8% despite beat/raised guidance is the same leverage-unwind story; October analyst day is the catalyst. BofA's "10% more downside, but cheap at 20x PE vs 70% EPS growth" thesis still holds — buy the dip on fundamentals, not the tape.
Tariff overhang persists into Broadcom's Sept 2 earnings (server/laptop/console tariff threat still "baseless speculation" per White House, still undenied). Canada retaliation lands Sept 8 — structurally unresolved, weighing on autos.
Unchanged/still working: Biotech (XBI +34% YTD), Goldman financials-heavy favorites (+29% YTD), AI infrastructure buildout (bank C&I lending +10% YoY funding it, AMD Saudi HUMAIN live, SpaceX-as-hyperscaler ~5% of NVDA revenue).